Metraipolis › archive › dc_0d7dae09e2b8
Real-world survival outcomes of neoadjuvant versus adjuvant chemotherapy in operable triple-negative breast cancer: a propensity score matched registry-based… — Europe PMC PMID:41036550
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41036550
- DOI
- 10.2340/1651-226x.2025.43990
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T15:43:04.206Z
- SHA-256 of the archived text
b7725b68cfb0ba8dd05e21725b8ef9e50d19d3b5862e2694f190931b0c376d4d- Stable URL of this page
https://metraipolis.com/documento/dc_0d7dae09e2b8
How to cite
Real-world survival outcomes of neoadjuvant versus adjuvant chemotherapy in operable triple-negative breast cancer: a propensity score matched registry-based… — Europe PMC PMID:41036550 — Europe PMC (en), https://europepmc.org/article/MED/41036550 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0d7dae09e2b8 (Metraipolis archive dc_0d7dae09e2b8, sha256 b7725b68cfb0ba8dd05e21725b8ef9e50d19d3b5862e2694f190931b0c376d4d)
BibTeX
@misc{dc0d7dae09e2b8,
title = {Real-world survival outcomes of neoadjuvant versus adjuvant chemotherapy in operable triple-negative breast cancer: a propensity score matched registry-based… — Europe PMC PMID:41036550},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41036550},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0d7dae09e2b8; sha256 b7725b68cfb0ba8dd05e21725b8ef9e50d19d3b5862e2694f190931b0c376d4d},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41036550. Agents can read the archived copy with the MCP tool read_document.